Long term survival in persons with hemophilia and chronic hepatitis C: 40 year outcomes of a large single center cohort

Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection

(2015) Stefan Zeuzem et al.   ANNALS OF INTERNAL MEDICINE

Natural History of Hepatitis C

(2015) Shilpa Lingala et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

(2015) Graham R. Foster et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

(2015) Jordan J. Feld et al.   NEW ENGLAND JOURNAL OF MEDICINE

Natural history of hepatitis C

(2014) Rachel H. Westbrook et al.   JOURNAL OF HEPATOLOGY

Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

(2014) Jordan J. Feld et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders

(2013) Dietje Elisabeth Fransen van de Putte et al.   JOURNAL OF HEPATOLOGY

The history of the “natural history” of hepatitis C (1968-2009)

(2009) Leonard B. Seeff   LIVER INTERNATIONAL

Coping with the HIV epidemic 19822007: 25-year outcomes of the Hershey Haemophilia Cohort

(2008) M. E. EYSTER   HAEMOPHILIA

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression

(2008) Hla-Hla Thein et al.   HEPATOLOGY